Molecular Subtype
Chronic Myeloid Leukemia, Philadelphia Chromosome Negative, BCR-ABL1 Positive
CI-CAN-00004951Explore in graph →
Hematologic3 approved drugs
- NCIt
- C9129
Loading cancer entity…
Molecular Subtype
CI-CAN-00004951Explore in graph →
Clinical trials
10 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (2)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07814560 | Metabolic Syndrome and Risk of Chronic Philadelphia Negative Myeloproliferative Neoplasms(MetSaMyeloprof) | not yet recruiting | — | 313 | Assiut UniversityOTHER | 0 | Sep 11, 2026 | clinicaltrials |
Data updated 18 days agoSource updated Sep 11, 2026source: clinicaltrials